DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f5qsjn/investigation) has announced the addition of the "Investigation Report on China's Bromhexine Market, 2010-2019" report to their offering.
As air pollution worsens, the incidence of respiratory disease keeps growing and so does the market size of relevant drugs. Bromhexine, a semisynthetic derivative of vasicine, is a mucolytic agent used in the treatment of chronic bronchitis and asthma associated with viscid or excessive mucus. It can make the phlegm thinner and less viscous by splitting polysaccharides and cellulose in mucus. Bromhexine is contained in various formulations like tablets and injections.
Bromhexine, an effective ingredient of Adhatoda vasica Nees which is an Indian folk expectorant, was first synthesized by Keck in 1963 and came into the market in many countries like Germany, Italy, Britain and France in 1965. In 1973, bromhexine began its production in China and has been written into the Chinese pharmacopoeia.
In recent years, bromhexine develops fast in China with annual sales rising from less than CNY 4 million in 2005 to CNY 87.44 million in 2014 and CAGR during this period reaching up to 41%. Currently, bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd and Ma'anshan BBCA Pharmaceutical Co., Ltd, among which Jiangxi Kelun Pharmaceutical Co., Ltd has the largest market share of 32% for sales value in 2014. The market size of bromhexine is expected to grow further in the next few years in China.
Key Topics Covered:
1 Related Concepts of Bromhexine
2 Market Profile of Bromhexine in China
3 Survey on Sales Status of Bromhexine in China, 2010-2014
4 Survey on Market Share of Major Manufacturers of Bromhexine in China, 2010-2014
5 Survey on Dosage Forms of Bromhexine in China, 2010-2014
6 Reference Price of Bromhexine in Chinese Hospitals in 2014
7 Major Manufacturers of Bromhexine in Chinese Market, 2010-2014
8 Market Outlook of Bromhexine in China, 2015-2019
- Jiangxi Kelun Pharmaceutical Co., Ltd
- Jincheng Haisi Pharmaceutical Co., Ltd
- Shanxi Powerdone Pharmaceutical Co., Ltd
- Shijiazhuang No.4 Pharmaceutical Co., Ltd
- Ma'anshan BBCA Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/f5qsjn/investigation